固有免疫反应和艰难梭菌感染的结果取决于老年宿主粪便细菌的组成。
Innate Immune Response and Outcome of Clostridium difficile Infection Are Dependent on Fecal Bacterial Composition in the Aged Host.
机构信息
Departments of Medicine, University of Virginia, Charlottesville.
Biology, University of Virginia, Charlottesville.
出版信息
J Infect Dis. 2018 Jan 4;217(2):188-197. doi: 10.1093/infdis/jix414.
Abstract
BACKGROUND
Clostridium difficile infection (CDI) is a serious threat for an aging population. Using an aged mouse model, we evaluated the effect of age and the roles of innate immunity and intestinal microbiota.
METHODS
Aged (18 months) and young (8 weeks) mice were infected with C difficile, and disease severity, immune response, and intestinal microbiome were compared. The same experiment was repeated with intestinal microbiota exchange between aged and young mice before infection.
RESULTS
Higher mortality was observed in aged mice with weaker neutrophilic mobilization in blood and intestinal tissue and depressed proinflammatory cytokines in early infection. Microbiota exchange improved survival and early immune response in aged mice. Microbiome analysis revealed that aged mice have significant deficiencies in Bacteroidetes phylum and, specifically, Bacteroides, Alistipes, and rc4-4 genera, which were replenished by cage switching.
CONCLUSIONS
Microbiota-dependent alteration in innate immune response early on during infection may explain poor outcome in aged host with CDI.
摘要
背景
艰难梭菌感染（CDI）是老龄化人口的严重威胁。本研究使用老年小鼠模型，评估了年龄的影响以及固有免疫和肠道微生物群的作用。
方法
用艰难梭菌感染老年（18 个月）和年轻（8 周）小鼠，比较疾病严重程度、免疫反应和肠道微生物组。在感染前，进行肠道微生物群交换实验，比较老年和年轻小鼠之间的相同实验。
结果
老年小鼠死亡率更高，血液和肠道组织中中性粒细胞动员减弱，早期感染时促炎细胞因子水平降低。菌群交换改善了老年小鼠的存活和早期免疫反应。微生物组分析显示，老年小鼠在拟杆菌门和特定的拟杆菌属、alistipes 属和 rc4-4 属存在显著缺陷，通过笼间交换得到补充。
结论
感染早期固有免疫反应的菌群依赖性改变可能解释了 CDI 老年宿主不良预后的原因。
相似文献
1
Innate Immune Response and Outcome of Clostridium difficile Infection Are Dependent on Fecal Bacterial Composition in the Aged Host.固有免疫反应和艰难梭菌感染的结果取决于老年宿主粪便细菌的组成。
J Infect Dis. 2018 Jan 4;217(2):188-197. doi: 10.1093/infdis/jix414.
2
Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile).粪便微生物移植治疗复发性艰难梭菌（艰难梭菌）。
Cochrane Database Syst Rev. 2023 Apr 25;4(4):CD013871. doi: 10.1002/14651858.CD013871.pub2.
3
Positive Intervention of Distinct Peptides in Clostridioides difficile Infection in a Mouse Model.不同肽类在艰难梭菌感染小鼠模型中的积极干预作用。
Commun Biol. 2024 Sep 18;7(1):1172. doi: 10.1038/s42003-024-06850-x.
4
Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植受者肠道微生物群中抵抗艰难梭菌感染的保护因素
J Infect Dis. 2017 Apr 1;215(7):1117-1123. doi: 10.1093/infdis/jix011.
5
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.用于预防成人和儿童艰难梭菌相关性腹泻的益生菌
Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4.
6
Fecal Microbiota Transplantation (FMT) in Clostridium difficile Infection: A Paradigm Shift in Gastrointestinal Microbiome Modulation.艰难梭菌感染中的粪便微生物群移植（FMT）：胃肠道微生物组调节的范式转变
Cureus. 2025 May 29;17(5):e85054. doi: 10.7759/cureus.85054. eCollection 2025 May.
7
Safety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized Controlled Trial.CP101的安全性和耐受性，一种用于预防艰难梭菌反复感染的全谱口服微生物组疗法：一项2期随机对照试验。
Gastroenterology. 2025 Feb;168(2):357-366.e3. doi: 10.1053/j.gastro.2024.09.030. Epub 2024 Oct 2.
8
Antibiotic treatment for Clostridium difficile-associated diarrhoea in adults.成人艰难梭菌相关性腹泻的抗生素治疗
Cochrane Database Syst Rev. 2017 Mar 3;3(3):CD004610. doi: 10.1002/14651858.CD004610.pub5.
9
The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants' life: a systematic review.分娩方式影响婴儿出生后第一年肠道微生物群的多样性和定植模式：一项系统综述。
BMC Gastroenterol. 2016 Jul 30;16(1):86. doi: 10.1186/s12876-016-0498-0.
10
Roles of Gut Microbiota and Associated Metabolites in Infection.肠道微生物群及其相关代谢产物在感染中的作用。
Pol J Microbiol. 2025 Jun 18;74(2):206-217. doi: 10.33073/pjm-2025-017. eCollection 2025 Jun 1.
引用本文的文献
1
Recurrent Clostridioides difficile Infection (CDI) in Patients Treated With Vancomycin at Johns Hopkins Aramco Healthcare (JHAH), Dhahran, Saudi Arabia.沙特阿拉伯达兰市约翰霍普金斯阿美医疗保健公司（JHAH）接受万古霉素治疗的患者复发性艰难梭菌感染（CDI）
Cureus. 2025 May 31;17(5):e85116. doi: 10.7759/cureus.85116. eCollection 2025 May.
2
Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations.核酸疫苗：创新、疗效及在高危人群中的应用
Front Immunol. 2025 May 14;16:1584876. doi: 10.3389/fimmu.2025.1584876. eCollection 2025.
3
Systemic neutrophil degranulation and emergency granulopoiesis in patients with Clostridioides difficile infection.艰难梭菌感染患者的系统性中性粒细胞脱颗粒和紧急粒细胞生成。
Anaerobe. 2024 Jun;87:102840. doi: 10.1016/j.anaerobe.2024.102840. Epub 2024 Mar 20.
4
The leaky gut and the gut microbiome in sepsis - targets in research and treatment.肠漏和脓毒症中的肠道微生物组——研究和治疗的靶点。
Clin Sci (Lond). 2023 Apr 26;137(8):645-662. doi: 10.1042/CS20220777.
5
Adenosine receptors differentially mediate enteric glial cell death induced by Toxins A and B.腺苷受体差异调节毒素 A 和 B 诱导的肠胶质细胞死亡。
Front Immunol. 2023 Jan 16;13:956326. doi: 10.3389/fimmu.2022.956326. eCollection 2022.
6
ADS024, a strain, protects human colonic epithelial cells against toxin-mediated apoptosis.菌株ADS024可保护人结肠上皮细胞免受毒素介导的凋亡。
Front Microbiol. 2023 Jan 10;13:1072534. doi: 10.3389/fmicb.2022.1072534. eCollection 2022.
7
Are Older People Really More Susceptible to SARS-CoV-2?老年人真的更容易感染新冠病毒吗？
Aging Dis. 2022 Oct 1;13(5):1336-1347. doi: 10.14336/AD.2022.0130.
8
Role of Pannexin-1-P2X7R signaling on cell death and pro-inflammatory mediator expression induced by toxins in enteric glia.缝隙连接蛋白 1-P2X7R 信号通路在毒素诱导肠神经胶质细胞死亡和促炎介质表达中的作用。
Front Immunol. 2022 Aug 22;13:956340. doi: 10.3389/fimmu.2022.956340. eCollection 2022.
9
A gut-centric view of aging: Do intestinal epithelial cells contribute to age-associated microbiota changes, inflammaging, and immunosenescence?从肠道角度看衰老：肠道上皮细胞是否会导致与年龄相关的微生物组变化、炎症衰老和免疫衰老？
Aging Cell. 2022 Sep;21(9):e13700. doi: 10.1111/acel.13700. Epub 2022 Aug 24.
10
Comprehensive 16S rRNA and metagenomic data from the gut microbiome of aging and rejuvenation mouse models.衰老和返老还童小鼠模型肠道微生物组的综合 16S rRNA 和宏基因组数据。
Sci Data. 2022 May 10;9(1):197. doi: 10.1038/s41597-022-01308-3.
本文引用的文献
1
Diverse Intestinal Bacteria Contain Putative Zwitterionic Capsular Polysaccharides with Anti-inflammatory Properties.多种肠道细菌含有具有抗炎特性的假定两性离子荚膜多糖。
Cell Host Microbe. 2016 Oct 12;20(4):535-547. doi: 10.1016/j.chom.2016.09.002. Epub 2016 Sep 29.
2
Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.万古霉素治疗改变艰难梭菌感染老年小鼠模型中的体液免疫和肠道微生物群。
J Infect Dis. 2016 Jul 1;214(1):130-9. doi: 10.1093/infdis/jiw071. Epub 2016 Feb 24.
3
Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections.从免疫学角度来看，年龄越大并不意味着越明智：衰老对宿主应对艰难梭菌感染的影响。
J Gerontol A Biol Sci Med Sci. 2016 Jul;71(7):916-22. doi: 10.1093/gerona/glv229. Epub 2016 Jan 25.
4
Pglyrp-Regulated Gut Microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii Enhance and Alistipes finegoldii Attenuates Colitis in Mice.Pglyrp调节的肠道微生物群——假普雷沃氏菌、解木聚糖拟杆菌和埃氏拟杆菌增强小鼠结肠炎，而芬氏嗜胆菌减轻小鼠结肠炎。
PLoS One. 2016 Jan 4;11(1):e0146162. doi: 10.1371/journal.pone.0146162. eCollection 2016.
5
Clostridium difficile infection.艰难梭菌感染
N Engl J Med. 2015 Apr 16;372(16):1539-48. doi: 10.1056/NEJMra1403772.
6
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.精准微生物群重建可恢复胆汁酸介导的对艰难梭菌的抗性。
Nature. 2015 Jan 8;517(7533):205-8. doi: 10.1038/nature13828. Epub 2014 Oct 22.
7
Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via nod-like receptor ligands.肺部对细菌感染的早期固有免疫由共生微生物群通过核苷酸结合寡聚化结构域样受体配体进行系统性调节。
Infect Immun. 2014 Nov;82(11):4596-606. doi: 10.1128/IAI.02212-14. Epub 2014 Aug 18.
8
Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.微生物组数据可将艰难梭菌感染患者、非艰难梭菌相关性腹泻患者与健康对照区分开来。
mBio. 2014 May 6;5(3):e01021-14. doi: 10.1128/mBio.01021-14.
9
In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B.体内生理和转录谱分析揭示了宿主对艰难梭菌毒素 A 和毒素 B 的反应。
Infect Immun. 2013 Oct;81(10):3814-24. doi: 10.1128/IAI.00869-13. Epub 2013 Jul 29.
10
Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection.肠道炎症标志物与艰难梭菌感染的临床结局相关，而不是与细菌负荷相关。
Clin Infect Dis. 2013 Jun;56(12):1713-21. doi: 10.1093/cid/cit147. Epub 2013 Mar 13.
Zotero 插件